Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 03-06-2020 | Practice Area: | Equity Capital Markets |
| Deal Title: | Intellia Therapeutics, Inc Underwritten Offering of Common Stock | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Intellia Therapeutics, Inc., a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, announced the pricing of an underwritten public offering of 5,479,453 shares of its common stock at a public offering price of USD18.25 per share. Intellia also granted the underwriters a 30-day option to purchase up to an additional 821,917 shares of its common stock.
Latham and Watkins LLP represents the underwriters in the transaction.
|
||
| Financial Center: | New York | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Latham & Watkins |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NYSE: |
Lawyer | Nathan Ajiashvili |
